Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Vanter is a Mexican pharmaceutical company specializing in the development, manufacturing, and distribution of high-specialty medicines. Founded in 1993, the company focuses on therapeutic areas such as oncology, nephrology, hematology, and rheumatology, providing both generic and specialized treatments for complex conditions. Vanter operates its own manufacturing facilities in Naucalpan, Mexico, which are certified for Good Manufacturing Practices (GMP). The company is a significant supplier to both the public and private healthcare sectors in Mexico, offering a portfolio that includes small molecules and biosimilars. Vanter is recognized for its commitment to providing accessible, high-quality treatments for chronic and life-threatening diseases.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Vanter.